A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.

Phase 2/3 Not yet recruiting 914 enrolled Shandong Suncadia Medicine Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy and safety of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension. To explore the optimal use of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension。

Timeline

Start: 2026-07
Primary completion: 2029-04
Completion: 2029-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-1780	Small molecule	—	—

A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.

Summary

Timeline

Drugs

Indications